Immunogen | BiotechTV

top of page

Jul 31, 2023

Immunogen’s CEO comments on Q2 earnings

Mark Enyedy discusses how the launch of the antibody-drug conjugate Elahere in platinum resistant ovarian cancer is progressing.

Discussing the MIRASOL ovarian cancer data with Immunogen at #ASCO23

Jun 4, 2023

Company News

Discussing the MIRASOL ovarian cancer data with Immunogen at #ASCO23

Immunogen CEO Mark Enyedy describes Elahere’s MIRASOL trial result and what it means for ovarian cancer and ADCs.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE